Abbott Laboratories (ABT) Change in Acquisitions & Divestments (2017)
Abbott Laboratories' (ABT) quarterly Change in Acquisitions & Divestments came in at -$1.8 billion in Q4 2017, down 3586.79% quarter-over-quarter from $53.0 million in Q3 2017.
Abbott Laboratories (ABT) Change in Acquisitions & Divestments (2017) Analysis & Trends
Abbott Laboratories has disclosed Change in Acquisitions & Divestments across 1 years of filings, most recently posting -$1.8 billion for Q4 2017.
- Change in Acquisitions & Divestments for Q4 2017 came in at -$1.8 billion, changed N/A year-over-year; the trailing twelve-month figure through Dec 2017 was $129.0 million (changed N/A YoY), and the FY2025 annual result was $3.0 million, down 89.29% from the prior year.
- Change in Acquisitions & Divestments came in at -$1.8 billion for Q4 2017 at Abbott Laboratories, down from $53.0 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $1.7 billion in Q1 2017 to a low of -$1.8 billion in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | -1.85 Bn |
| Dec 31, 2017 | -1.85 Bn |
| Sep 30, 2017 | 53.00 Mn |
| Sep 30, 2017 | 53.00 Mn |
| Jun 30, 2017 | 239.00 Mn |
| Jun 30, 2017 | 239.00 Mn |
| Mar 31, 2017 | 1.69 Bn |
| Mar 31, 2017 | 1.69 Bn |